Over-expression of Eukaryotic Translation Initiation Factor 4 Gamma 1 Correlates with Tumor Progression and Poor Prognosis in Nasopharyngeal Carcinoma

Overview

Journal Mol Cancer

Publisher Biomed Central

Specialties Molecular Biology
Oncology

Date 2010 Apr 20

PMID 20398343

Citations 41

Authors

Luxia Tu

Zhen Liu

Xiufang He

Ying He

Huiling Yang

Qingping Jiang

Siming Xie

Guanghui Xiao

Xin Li

Kaitai Yao

Weiyi Fang

Affiliations

Soon will be listed here.

Abstract

Background: The aim of the present study was to analyze the expression of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in nasopharyngeal carcinoma (NPC) and its correlation with clinicopathologic features, including patients' survival time.

Methods: Using real-time PCR, we detected the expression of EIF4G1 in normal nasopharyngeal tissues, immortalized nasopharyngeal epithelial cell lines NP69, NPC tissues and cell lines. EIF4G1 protein expression in NPC tissues was examined using immunohistochemistry. Survival analysis was performed using Kaplan-Meier method. The effect of EIF4G1 on cell invasion and tumorigenesis were investigated.

Results: The expression levels of EIF4G1 mRNA were significantly greater in NPC tissues and cell lines than those in the normal nasopharyngeal tissues and NP69 cells (P < 0.001). Immunohistochemical analysis revealed that the expression of EIF4G1 protein was higher in NPC tissues than that in the nasopharyngeal tissues (P < 0.001). In addition, the levels of EIF4G1 protein in tumors were positively correlated with tumor T classification (P = 0.039), lymph node involvement (N classification, P = 0.008), and the clinical stages (P = 0.003) of NPC patients. Patients with higher EIF4G1 expression had shorter overall survival time (P = 0.019). Multivariate analysis showed that EIF4G1 expression was an independent prognostic indicator for the overall survival of NPC patients. Using shRNA to knock down the expression of EIF4G1 not only markedly inhibited cell cycle progression, proliferation, migration, invasion, and colony formation, but also dramatically suppressed in vivo xenograft tumor growth.

Conclusion: Our data suggest that EIF4G1 can serve as a biomarker for the prognosis of NPC patients.

Citing Articles

KMO-driven metabolic reconfiguration and its impact on immune cell infiltration in nasopharyngeal carcinoma: a new avenue for immunotherapy.

Chen N, Zong Y, Yang C, Li L, Yi Y, Zhao J Cancer Immunol Immunother. 2025; 74(3):75.

PMID: 39891699 PMC: 11787144. DOI: 10.1007/s00262-024-03928-7.

Exploiting Translation Machinery for Cancer Therapy: Translation Factors as Promising Targets.

Sehrawat U Int J Mol Sci. 2024; 25(19).

PMID: 39409166 PMC: 11477148. DOI: 10.3390/ijms251910835.

USP10 promotes cell proliferation, migration, and invasion in NSCLC through deubiquitination and stabilization of EIF4G1.

Li F, He Z, Zhang X, Gao D, Xu R, Zhang Z Sci Rep. 2024; 14(1):23685.

PMID: 39390016 PMC: 11467297. DOI: 10.1038/s41598-024-74490-6.

Knockdown of in NSCLC induces CXCL8 secretion.

He Z, Li F, Zhang X, Gao D, Zhang Z, Xu R Front Pharmacol. 2024; 15:1346383.

PMID: 38405671 PMC: 10884238. DOI: 10.3389/fphar.2024.1346383.

Prognostic and functional roles of EIF4G1 in lung squamous cell carcinoma.

Bai B, Dong L, Feng M, Zhang Z, Lu Y, Xu Z Hum Cell. 2023; 36(3):1099-1107.

PMID: 36897548 PMC: 10110680. DOI: 10.1007/s13577-023-00884-9.

References

Ozyar E, Ayhan A, Korcum A, Atahan I . Prognostic role of Ebstein-Barr virus latent membrane protein-1 and interleukin-10 expression in patients with nasopharyngeal carcinoma. Cancer Invest. 2004; 22(4):483-91. DOI: 10.1081/cnv-200026386. View

Jiang W, Liao Y, Zhao S, Wu B, Zhou R, Wei R . Role of enhanced radiosensitivity and the tumor-specific suicide gene vector in gene therapy of nasopharyngeal carcinoma. J Radiat Res. 2007; 48(3):211-8. DOI: 10.1269/jrr.06056. View

Prevot D, Darlix J, Ohlmann T . Conducting the initiation of protein synthesis: the role of eIF4G. Biol Cell. 2003; 95(3-4):141-56. DOI: 10.1016/s0248-4900(03)00031-5. View

Yoshida M, Tomitori H, Machi Y, Hagihara M, Higashi K, Goda H . Acrolein toxicity: Comparison with reactive oxygen species. Biochem Biophys Res Commun. 2008; 378(2):313-8. DOI: 10.1016/j.bbrc.2008.11.054. View

Silvera D, Arju R, Darvishian F, Levine P, Zolfaghari L, Goldberg J . Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nat Cell Biol. 2009; 11(7):903-8. DOI: 10.1038/ncb1900. View

Wang S, Zhou J, Wang X, Hao J, Chen J, Zhang X . Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer. J Pathol. 2009; 219(1):114-22. DOI: 10.1002/path.2575. View

Hsiao J, Chang K, Chen C, Wu S, Su I, Hsu M . Endoplasmic reticulum stress triggers XBP-1-mediated up-regulation of an EBV oncoprotein in nasopharyngeal carcinoma. Cancer Res. 2009; 69(10):4461-7. DOI: 10.1158/0008-5472.CAN-09-0277. View

Cromer A, Carles A, Millon R, Ganguli G, Chalmel F, Lemaire F . Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene. 2003; 23(14):2484-98. DOI: 10.1038/sj.onc.1207345. View

Braunstein S, Karpisheva K, Pola C, Goldberg J, Hochman T, Yee H . A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol Cell. 2007; 28(3):501-12. DOI: 10.1016/j.molcel.2007.10.019. View

10.

Yang H, Jansen A, Komar A, Zheng X, Merrick W, Costes S . The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol. 2002; 23(1):26-37. PMC: 140682. DOI: 10.1128/MCB.23.1.26-37.2003. View

11.

Xie S, Fang W, Liu Z, Wang S, Li X, Liu T . Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin. J Transl Med. 2008; 6:55. PMC: 2572589. DOI: 10.1186/1479-5876-6-55. View

12.

Ambrosini G, Adida C, Altieri D . A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997; 3(8):917-21. DOI: 10.1038/nm0897-917. View

13.

Ishii I, Kashiwagi K, Mashiba H, Ekimoto H, Igarashi K . Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res. 1997; 57(22):5041-4. View

14.

Chung J, Bachelder R, Lipscomb E, Shaw L, Mercurio A . Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J Cell Biol. 2002; 158(1):165-74. PMC: 2173018. DOI: 10.1083/jcb.200112015. View

15.

Averous J, Proud C . When translation meets transformation: the mTOR story. Oncogene. 2006; 25(48):6423-35. DOI: 10.1038/sj.onc.1209887. View

16.

Masunaga R, Kohno H, Dhar D, Ohno S, Shibakita M, Kinugasa S . Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res. 2000; 6(10):4064-8. View

17.

Song L, Yan J, Jian S, Zhang L, Li M, Li D . [Molecular mechanisms of tumorgenesis and metastasis in nasopharyngeal carcinoma cell sublines]. Ai Zheng. 2002; 21(2):158-62. View

18.

Bauer C, Brass N, Diesinger I, Kayser K, Grasser F, Meese E . Overexpression of the eukaryotic translation initiation factor 4G (eIF4G-1) in squamous cell lung carcinoma. Int J Cancer. 2002; 98(2):181-5. DOI: 10.1002/ijc.10180. View

19.

Chou J, Lin Y, Kim J, You L, Xu Z, He B . Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis. Head Neck. 2008; 30(7):946-63. PMC: 3046044. DOI: 10.1002/hed.20833. View

20.

Zakowicz H, Yang H, Stark C, Wlodawer A, LaRonde-LeBlanc N, Colburn N . Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI. RNA. 2005; 11(3):261-74. PMC: 1370716. DOI: 10.1261/rna.7191905. View